More than a quarter of a century after the Chernobyl nuclear disaster, many children and teenagers who developed thyroid cancer due to radiation are in complete or near remission, according to a recent study accepted for ...
Apr 24, 2013
0
0
Researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences have developed a fluorescence-based noninvasive detection device to allow for the rapid and non-invasive identification of parathyroid ...
Jul 7, 2023
0
1
(HealthDay)—The cancer drug sorafenib, known by its trade name Nexavar, could have a toxic effect on the pancreas of patients who take it for extended periods.
Oct 9, 2013
0
0
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, scientists report the discovery ...
Aug 20, 2020
0
5
The thyroid is a gland located at the base of the neck. It makes thyroid hormones, which control the way the body uses energy.
Apr 27, 2023
0
0
Patients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.
Apr 4, 2024
0
0
Johns Hopkins Medicine researchers say they have found that specific variations in three genes related to maintaining the length of telomeres—the protective DNA endcaps on chromosomes—may explain up to 4.5% of papillary ...
May 13, 2024
0
59
Thyroid cancer is a disease with good cure rates in most cases. In 5 percent of patients, however, the tumor becomes refractory to the available therapies and may spread all over the body, causing death.
Jan 19, 2018
0
13
(HealthDay)—First-degree, second-degree, and third-degree relatives of patients diagnosed with papillary thyroid cancer (PTC) are at significantly increased risk of developing the disease, according to research published ...
Oct 7, 2013
0
0
(HealthDay)—Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy, the agency said Friday in ...
Feb 13, 2015
0
3
